Increased susceptibility to LTP generation and changes in NMDA-NR1 and -NR2B subunits mRNA expression in rat hippocampus after MCH administration
Introduction
Many studies have demonstrated that the hippocampus is involved in the formation and in the expression of memory for one-trial step-down inhibitory avoidance task in rats [3], [4], [36], [56] and is an essential structure for the memory and learning processes [2], [40], [45], [58]. This is the task most often used for research on the mechanisms of memory formation and modulation because it is learned very rapidly and memory can be easily and reliably assessed for days, even or months following training. The use of this learned task in hippocampus has helped to identify the major modulatory and core mechanisms of memory formation, and the biochemical sequence of events for memory formation are now well known [17], [18], [19]. The sequence initially involves the activation of different types of glutamate receptors: the a-amino-3-hydroxy-5-methyl-4-isoxazole propoinic acid (AMPA), and the N-methyl-d-aspartate (NMDA) receptors [9], [17], [20], [57]. The NMDA receptors are associated with the remarkable plasticity of the hippocampus [11], and are crucially involved in the neural mechanisms underlying certain forms of learning. In this sense, these receptors have also been shown to be necessary for the induction of long-term potentiation (LTP) in hippocampal dentate gyrus [8], [15]. This activation of glutamate receptors is followed by changes in second messengers and biochemical cascades led by enhanced activity of protein kinases A, C, and G and also calcium-calmodulin protein kinase II, and changes in glutamate receptor subunits and binding properties [18], [19]. The molecular steps that are related to memory formation of inhibitory avoidance behavior in the rat hippocampus agrees with the events described to LTP [18]. LTP is considered be a neural form of memory [28].
The NMDA receptor is composed of combinations of NR1, NR2A–D, and NR3 subunits, [13], [29], with NR1 subunit being a necessary component of functional NMDA receptor channels [29]; the loss of NR1 from CA1 cells results in a selective loss of NMDAR function without affecting other glutamate receptors (e.g. AMPA receptors). In addition, neither NMDA-dependent LTP nor LTD can be induced in the CA1 region and also results in spatial learning deficits. In addition, it has recently been demonstrated that alterations in expression of synaptic NMDA NR1 subunits in the hippocampus are associated with memory formation of an inhibitory avoidance task [5]. Coexpression of the NR1subunits with NR2 subunits enhances the individual functional properties of the subunits, such as channel conductance, along with agonist, antagonist, and co-agonist sensitivities [30], [35]. Tang et al. [55] have demonstrated that the overexpression of the recombinant NR1/NR2B subunits results in a prolonged opening of the NMDA receptor channel. In addition, an enhanced tyrosine phosphorylation of NR2B subunit has been observed following LTP induction “in vivo” [43], [44].
Melanin-concentrating hormone (MCH) is a cyclic peptide first isolated from the salmon pituitary [22]. It is subsequently found to be present in mammals [53] and MCH-producing neurons located mainly in the lateral hypothalamus and zona incerta, and projects into a wide variety of brain regions [1]. This extensive distribution suggests that MCH plays many physiological functions in the central nervous system. Recently, MCH research has actively focused on its roles in the regulation of feeding behavior and energy balance [21], [41], [47]. Besides this effect, MCH is also involved in other neuronal processes such as anxiety [31], [33], learning [32], [51], and reproduction [14], [50].
In our laboratory we have studied the effect of micro-infusion of MCH in hippocampus in the one-trial step-down inhibitory avoidance test because MCH contains cells that project into the hippocampus [1], and also, a high density of specific binding sites for the peptide have been found in this area [12].
We have shown that the micro-infusion of MCH in hippocampus increases the latency time in the one-trial step-down inhibitory test when injected immediately after training, facilitating the formation and retention of memory [32]. These changes are correlated with a significant increase in NO and cGMP hippocampal levels suggesting that MCH activates certain steps of the early biochemical memory cascade [51]. Furthermore, we have demonstrated in an electrophysiological model, that MCH addition to the perfusion chamber causes a long-lasting increase in the efficacy of the hippocampal synaptic transmission and that previous perfusion with MK-801 (a non competitive NMDA receptor antagonist) was able to impair the potentiation elicited by MCH [52].
Thus, in order to investigate the neurobiological events underlying the behavioral effects induced by MCH, in the present research we have studied the effects of the neuropeptide upon the electrophysiological parameters using hippocampal slices from rats injected with the peptide and tested in step-down tests, as well as possible changes in the mRNA expression of NMDA receptor subunits.
Section snippets
Animals
The experiments were performed on male Wistar rats of 230–280 g (age, 9–12 weeks) with all experiments having food and water ad libitum. The animals were housed in plastic cages (four or five in a cage) under a 12 h-light/12 h-dark cycle (lights on at 7.00 a.m.) at a constant temperature of 23±1 °C. The experimental sessions were conducted during the light phase of the cycle. Each animal was used in only one experiment.
Surgery
The animals were anaesthetized with chloral hydrate (400 mg/kg; i.p.) and placed
Behavioral and electrophysiological studies
The effects of intrahippocampal administration of acsf (control animals) or rMCH upon latency time are shown in Fig. 1. The infusion of MCH (0.5 μg/side) into the hippocampus immediately after training (0 h) caused a significant increase in the latency time with respect to the control animals (P<0.05 for Mann–Whitney U test).
Fig. 2 shows the threshold necessary to induce LTP in our electrophysiological model, measured in hertz. It can be seen that rats treated with rMCH showed an increased
Discussion
Our previous behavioral data showed that intrahippocampal MCH injection increases the latency time in the step-down test when is administered immediately after the training session, indicating that the peptide modifies memory retention [32].
In the present study we have confirmed these previous results (Fig. 1), and examined changes in hippocampal LTP after testing. The fact that MCH diminished the threshold in LTP generation indicates a positive correlation between this phenomenon and the MCH
References (58)
- et al.
The human hippocampus and spatial and episodic memory
Neuron
(2002) - et al.
Mechanisms of emotional arousal and lasting declarative memory
Trends Neurosci.
(1998) Long-term potentiation in the hippocampus: mechanisms of intiation and modulation by neurotransmitters
Trends Pharmacol. Sci.
(1985)- et al.
Memories of NMDA receptors and LTP
Trends Neurosci.
(1995) - et al.
NMDA receptor subunit gene expression in the rat brain. A quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A
Mol. Brain Res.
(1999) - et al.
Long-term potentiation in the hippocampus involves activation of N-methyl-d-aspartate receptors
Brain Res.
(1984) - et al.
Long-term potentiation in the rat hippocampal CA1 region is inhibited selectively at the acquisition stage of discriminatory avoidance learning
Brain Res.
(1996) - et al.
Correlation between the pharmacology of long-term potentiation and the pharmacology of memory
Neurobiol. Learn. Mem.
(1995) - et al.
Neurobiol memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures
Learn. Mem.
(1997) - et al.
Amnesia by infusion of glutamate receptor blockers into the amygdala, hippocampus and entorhinal cortex
Behav. Neural. Biol.
(1992)
Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice
Neuron
Response to novelty after i.c.v. injection of melanin-concentrating hormone (MCH) in rats
Physiol. Behav.
Melanin-concentrating hormone (MCH) modifies memory retention in rats
Peptides
Anxiogenesis induced by nitric oxide synthase inhibition and anxiolytic effect of melanin-concentrating hormone (MCH) in rat brain
Peptides
Cloning of a novel G protein-coupled receptor, SLT, a subtype of the melanin-concentrating hormone receptor
Biochem. Biophys. Res. Commun.
Environmental changes modify the expresión of Diazepam withdrawal
Behav. Brain Res.
Correlation between threshold to induce long-term potentiation in the hippocampus and performance in a shuttle box avoidance response in rats
Neurosci. Lett.
The hippocampal formation is necessary for rats to learn and remember configural discriminations
Behav. Brain Res.
Melanin-concentrating hormone, hippocampal nitric oxide levels and memory retention
Peptides
Melanin concentrating hormone increase hippocampal synaptic transmission in the rat
Peptides
The melanin-concentrating hormone system of rat brain: an immuno-and hybridization histochemical characterization
J. Comp. Neurol.
A synaptic model of memory: long-term potentiation in the hippocampus
Nature
Rapid and transient learning-associated increase in NMDA NR1 subunit in the rat hippocampus
Neurochem. Res.
Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1
Nature
Subtype-dependence of NMDA receptor channel open probability
J. Neurosci.
Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus
J. Physiol.
Anatomical organization of excitatory amino acids receptors and their pathways
Trends Neurosci.
Binding the sites for melanin-concentrating hormone (MCH) in brain synaptosomes and membranes from peripheral tissues identified with highly tritiated MCH
J. Recept. Signal Transduct. Res.
Stimulatory effect of melanin-concentrating hormone on luteinizing hormone release
Neuroendocrinology
Cited by (34)
Acute intrahippocampal administration of melanin-concentrating hormone impairs memory consolidation and decreases the expression of MCHR-1 and TrkB receptors
2023, Progress in Neuro-Psychopharmacology and Biological PsychiatryCitation Excerpt :Specifically, we have shown that MCH impaired the consolidation process evaluated by hippocampal-dependent tasks (NORT and mEPM) and that such effects were dose-dependent and MCHR-1-dependent. Since it is well established that glutamatergic transmission and BDNF are involved in memory consolidation in the hippocampus, and that MCH increases the expression of mRNA of different subunits of NMDA receptors (Barnes et al., 2020; Varas et al., 2003), we studied the expression of the genes and proteins of NR1, NR2A and NR2B NMDA receptor subunits, BDNF and TrkB in the hippocampus 24 h after the administration of MCH (once rats were challenged with the novel object in the NORT retention trial). We also included the study of the hippocampal expression of the MCHR-1 gene and protein.
The hypothalamus as a primary coordinator of memory updating
2020, Physiology and BehaviorAntidepressant/anxiolytic potential and adverse effect liabilities of melanin-concentrating hormone receptor 1 antagonists in animal models
2015, Pharmacology Biochemistry and BehaviorHypothalamic melanin-concentrating hormone projections to the septo-hippocampal complex in the rat
2013, Journal of Chemical NeuroanatomyCitation Excerpt :Initially, MCH was characterized as participating in the control of memory processing, as described by de Barioglio and her group (Monzon and De Barioglio, 1999; Monzon et al., 1999), who found that MCH modulates memory early after training by acting on both the amygdala and hippocampus, as well as on the hippocampus alone by 4 h after training. Varas et al. (2003) postulate that the increased facility to induce long-term potentiation, and the overexpression of the N-methyl-d-aspartate mRNA receptor subunits induced by MCH, could be responsible for the retrograde facilitation observed after MCH microinjection into the hippocampus (Varas et al., 2003). Sanchez et al. injected NEI intracerebroventricularly (1 μg) and found that grooming, rearing and locomotor activities increased (Sanchez et al., 1997).
Mice lacking Melanin Concentrating Hormone 1 receptor are resistant to seizures
2010, Neuroscience Letters